Treatment
Treatment A clinical trials
We’re tracking 8,310 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT06752759RecruitingPhase 3
Ketamine mist for depression
This trial tests if a ketamine mist you breathe in can help treat moderate to severe depression. It is for adults who are not helped enough by other treatments.
Brooklyn, New YorkAges 18–88 - NCT06753812Enrolling by invitation
Lower limb therapy for children with unilateral cerebral palsy
This trial tests a therapy called constraint-induced movement therapy (CIMT) for the legs in children with unilateral cerebral palsy. It aims to improve leg function by encouraging use of the affected leg through structured exercises and activities.
BoluAges 5–15 - NCT06757647RecruitingPhase 2
Acalabrutinib for CLL/SLL patients with heart issues from ibrutinib
This trial tests a different targeted drug, acalabrutinib, for people with CLL or SLL who developed heart problems (like atrial fibrillation) while taking ibrutinib. The goal is to see if acalabrutinib can control the cancer without causing the same heart side effects.
Columbus, OhioAges 18 years+ - NCT06759636RecruitingPhase 3
Comparing two drugs for low platelets from cancer treatment
This trial tests if a new drug called Romiplostim N01 works better than the standard drug Interleukin-11 for raising low platelet counts caused by cancer treatments like chemotherapy or radiation. If you have low platelets from your cancer therapy, you may be able to join.
Nanjing, JiangsuAges 18–75 - NCT06755359Recruiting
Radioactive implant for locally advanced pancreatic cancer
This trial tests a new treatment called DaRT, which places tiny radioactive devices directly into your pancreatic tumor. It is for people with locally advanced pancreatic cancer that has not spread, after they have already had standard chemotherapy.
BordeauxAges 18–120 - NCT06757634RecruitingPhase 3
A study of gedatolisib for first-line advanced breast cancer
This trial tests a new targeted therapy called gedatolisib for people with HR-positive, HER2-negative advanced breast cancer who have not yet received treatment for metastatic disease. It aims to see if adding this drug to standard hormone therapy can help control the cancer longer.
Jonesboro, ArkansasAges 18 years+ - NCT06754891RecruitingPhase 1
A study of TQH3906 for moderate to severe inflammatory bowel disease
This trial tests a new medicine (TQH3906) for people with moderate to severe ulcerative colitis or Crohn's disease that hasn't improved with other treatments. The goal is to see if it can help control inflammation in the gut.
Bengbu, AnhuiAges 18–75 - NCT06755515Enrolling by invitationPhase 2/Phase 3
Rulonilimab + Chemo for Advanced Cervical Cancer
This trial tests a new drug called Rulonilimab combined with chemotherapy, with or without bevacizumab, as the first treatment for cervical cancer that has spread or come back. It’s for people whose tumors have a specific marker (PD-L1) and who haven’t had other treatments for advanced disease.
Linyi, ShandongAges 18 years+ - NCT06754735RecruitingPhase 4
Oxygen therapy for chronic leg ulcers
This study tests a new device that delivers oxygen to the wound area (topical wound oxygen therapy) to help heal chronic leg ulcers caused by vein disease. It may help people who have not seen enough healing with compression therapy alone.
New York, New YorkAges 18 years+ - NCT05969171RecruitingPhase 2
Surufatinib plus chemotherapy for advanced pancreatic cancer
This Phase 2 study tests whether adding surufatinib to first-line treatment (either AG or a similar AG-based regimen) can improve outcomes for people with locally advanced or metastatic pancreatic cancer. You may be considered if your cancer cannot be removed by surgery and you’ve already had a short course of similar treatment with a response.
ShanghaiAges 18–75 - NCT05595668Recruiting
Home computer therapy for brain neglect after stroke
This trial tests an at-home, phone/computer-based therapy to help people who have “neglect” after a stroke, using visual tasks to retrain attention. It may help improve how you notice and respond to the space on one side of your world.
Bedford, Nova ScotiaAges Any age - NCT06032559RecruitingPhase 3
Mindfulness and methadone for chronic pain
This study tests if adding a mindfulness program (MORE) to regular methadone treatment helps people with long-term pain. It may improve pain and support recovery.
New Brunswick, New JerseyAges 18 years+ - NCT06214767Recruiting
Study of treatment choices for untreated brain cavernous malformations
This study looks at how to best treat people with untreated cerebral cavernous malformations (a cluster of abnormal blood vessels in the brain). It compares outcomes between those who have surgery and those who are monitored with regular check-ups, and will follow participants for a long time to see how they do.
Beijing, Beijing MunicipalityAges Any age - NCT06745557RecruitingPhase 3
Testing a new lab-grown skin patch for large burns
This trial tests a new skin patch made from your own cells to treat large, deep burns. It’s for people who need skin grafts and may help reduce scarring and improve healing.
LiègeAges 12 years+ - NCT06743126RecruitingPhase 3
IMA203 vs standard treatment for advanced skin cancer
This trial tests a new cell therapy called IMA203 against standard treatments for people with advanced melanoma (a type of skin cancer) that has spread or can't be removed. It may be an option if you have already tried certain treatments and your cancer has a specific cell marker (HLA-A*02:01).
Phoenix, ArizonaAges 18 years+ - NCT05821075RecruitingPhase 1/Phase 2
Prednisolone vs Cerebrolysin for sudden facial weakness
This early-stage study compares two medicines—prednisolone and cerebrolysin—to see which works better for Bell’s palsy (sudden one-sided facial weakness with no clear cause). You may be asked to take one of the study treatments and be followed to measure how well facial movement improves.
GizaAges 18–60 - NCT06747013Enrolling by invitation
Focused pulse field ablation for ventricular tachycardia
This trial tests a new way to treat rapid heartbeats from the lower chambers (ventricles) using a special catheter that delivers short electrical pulses to stop the abnormal signals. It may help people with extra beats (PVCs) or a fast heart rhythm (ventricular tachycardia) that needs treatment.
New York, New YorkAges 18 years+ - NCT06739356Recruiting
Balloon treatment study for severe diaphragmatic hernia in babies
This study tests a fetal surgery (fetoscopic tracheal balloon placement) to help lungs grow in babies with a severe hole in the diaphragm. It focuses on pregnancies where the liver is also in the chest and lung size is very small.
Houston, TexasAges 18 years+ - NCT06738797Recruiting
SPHERTEST test to predict immunotherapy response for advanced bladder cancer
This trial tests whether a lab test (SPHERTEST) can predict how well patients with advanced bladder or urinary tract cancer respond to immunotherapy treatments. If you are starting immunotherapy for this cancer, you may be eligible.
MontpellierAges 18 years+ - NCT06748209RecruitingPhase 4
Mobile TMS for treatment-resistant depression
This trial tests if delivering transcranial magnetic stimulation (TMS) through a mobile unit can help people with depression that hasn't improved with other treatments.
Charleston, South CarolinaAges 22–80 - NCT06746220Recruiting
Effect of activity and probiotics on body and health in women
This study looks at how adding physical activity and/or probiotics might affect your body composition and health. It is for women who are students at the University of Orléans and do not already exercise regularly.
OrléansAges 18 years+ - NCT06745076RecruitingPhase 2
Personalized chemotherapy reduction for advanced Hodgkin lymphoma
This trial tests a personalized approach to using a blood test (ctDNA) to decide how much chemotherapy you need. If you have advanced Hodgkin lymphoma, this study might let you have less chemo if the blood test shows a strong response early on, potentially reducing side effects.
Irvine, CaliforniaAges 18 years+ - NCT06739967Recruiting
Speech Therapy for Italian Speakers with PPA
This study tests speech and language therapy for people with primary progressive aphasia (PPA). It aims to see if targeted exercises can help maintain or improve communication skills.
BariAges 40–85 - NCT06742931Recruiting
Balloon vs stent for heart artery blockages in high bleeding risk patients
This trial compares a drug-coated balloon (medicated balloon) to a drug-eluting stent (medicated mesh tube) for treating new blockages in heart arteries. It is designed for patients with a high risk of bleeding who have completed a short course of anti-clotting medication and have been event-free for at least one year.
AnsanAges 19 years+
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,310 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.